Outsourced Compounding Expansions

September 2020 - Vol.17 No. 9 - Page #6
Category: Outsourced Compounding Services (503B)

Outsourced compounding remains an intrinsic component of many facilities’ compounding production plans. Outsourced compounding utilization grew by 10% this year and this growth is expected to continue as some facilities look to expand their outsourced volumes, while other facilities evaluate new vendors.

A growing number of facilities (42%) are considering changing or adding additional vendors to their outsourcing plan, yet just 9% are currently taking concrete steps to do so.

Most facilities (57%) plan to maintain their current outsourcing volume over the next 3 years, while 26% of pharmacy directors are planning to order additional CSPs from their outsourced vendors.

For those facilities looking to add or switch outsourced compounding vendors, Nephron, CAPS, and Quva are the leading vendors under consideration.

Click here to view a larger version of this Figure


Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue